Goldman Sachs Group Inc Roivant Sciences Ltd. Call Options Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
Call Options
1 transactions
Others Institutions Holding ROIV
# of Institutions
310Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$791 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$790 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$649 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$500 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$424 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.45B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...